These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 20436290)

  • 1. The molecular dynamics of MDM2.
    Nicholson J; Hupp TR
    Cell Cycle; 2010 May; 9(10):1878-81. PubMed ID: 20436290
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential binding of p53 and nutlin to MDM2 and MDMX: computational studies.
    Joseph TL; Madhumalar A; Brown CJ; Lane DP; Verma CS
    Cell Cycle; 2010 Mar; 9(6):1167-81. PubMed ID: 20190571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformational changes of the p53-binding cleft of MDM2 revealed by molecular dynamics simulations.
    Espinoza-Fonseca LM; Trujillo-Ferrara JG
    Biopolymers; 2006 Nov; 83(4):365-73. PubMed ID: 16817233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis for the conserved binding mechanism of MDM2-inhibiting peptides and anti-apoptotic Bcl-2 family proteins.
    Lee MS; Ha JH; Yoon HS; Lee CK; Chi SW
    Biochem Biophys Res Commun; 2014 Feb; 445(1):120-5. PubMed ID: 24491548
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mimicking a p53-MDM2 interaction based on a stable immunoglobulin-like domain scaffold.
    Jimenez-Sandoval P; Madrigal-Carrillo EA; Santamaría-Suárez HA; Maturana D; Rentería-González I; Benitez-Cardoza CG; Torres-Larios A; Brieba LG
    Proteins; 2018 Jul; 86(7):802-812. PubMed ID: 29696695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis of competitive recognition of p53 and MDM2 by HAUSP/USP7: implications for the regulation of the p53-MDM2 pathway.
    Hu M; Gu L; Li M; Jeffrey PD; Gu W; Shi Y
    PLoS Biol; 2006 Feb; 4(2):e27. PubMed ID: 16402859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative lid dynamics of MDM2 reveals differential ligand binding modes of the p53-binding cleft.
    Showalter SA; Bruschweiler-Li L; Johnson E; Zhang F; Brüschweiler R
    J Am Chem Soc; 2008 May; 130(20):6472-8. PubMed ID: 18435534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of p53 peptide analogues to anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy.
    Shin JS; Ha JH; Chi SW
    Biochem Biophys Res Commun; 2014 Jan; 443(3):882-7. PubMed ID: 24342622
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct observations of conformational distributions of intrinsically disordered p53 peptides using UV Raman and explicit solvent simulations.
    Xiong K; Zwier MC; Myshakina NS; Burger VM; Asher SA; Chong LT
    J Phys Chem A; 2011 Sep; 115(34):9520-7. PubMed ID: 21528875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High affinity interaction of the p53 peptide-analogue with human Mdm2 and Mdmx.
    Czarna A; Popowicz GM; Pecak A; Wolf S; Dubin G; Holak TA
    Cell Cycle; 2009 Apr; 8(8):1176-84. PubMed ID: 19305137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simulating molecular mechanisms of the MDM2-mediated regulatory interactions: a conformational selection model of the MDM2 lid dynamics.
    Verkhivker GM
    PLoS One; 2012; 7(7):e40897. PubMed ID: 22815859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding Ensembles of
    Lang L; Perez A
    Molecules; 2021 Jan; 26(1):. PubMed ID: 33401765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conservation of Affinity Rather Than Sequence Underlies a Dynamic Evolution of the Motif-Mediated p53/MDM2 Interaction in Ray-Finned Fishes.
    Mihalič F; Arcila D; Pettersson ME; Farkhondehkish P; Andersson E; Andersson L; Betancur-R R; Jemth P
    Mol Biol Evol; 2024 Feb; 41(2):. PubMed ID: 38301272
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple peptide conformations give rise to similar binding affinities: molecular simulations of p53-MDM2.
    Dastidar SG; Lane DP; Verma CS
    J Am Chem Soc; 2008 Oct; 130(41):13514-5. PubMed ID: 18800837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Mechanism of p53 Rescue by SUSP4.
    Kim DH; Lee C; Lee SH; Kim KT; Han JJ; Cha EJ; Lim JE; Cho YJ; Hong SH; Han KH
    Angew Chem Int Ed Engl; 2017 Jan; 56(5):1278-1282. PubMed ID: 28000315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A spatiotemporal characterization of the effect of p53 phosphorylation on its interaction with MDM2.
    ElSawy KM; Sim A; Lane DP; Verma CS; Caves LS
    Cell Cycle; 2015; 14(2):179-88. PubMed ID: 25584963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein-peptide molecular docking with large-scale conformational changes: the p53-MDM2 interaction.
    Ciemny MP; Debinski A; Paczkowska M; Kolinski A; Kurcinski M; Kmiecik S
    Sci Rep; 2016 Dec; 6():37532. PubMed ID: 27905468
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determinants of specificity of MDM2 for the activation domains of p53 and p65: proline27 disrupts the MDM2-binding motif of p53.
    Zondlo SC; Lee AE; Zondlo NJ
    Biochemistry; 2006 Oct; 45(39):11945-57. PubMed ID: 17002294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient reactivation of p53 in cancer cells by a dual MdmX/Mdm2 inhibitor.
    Qin L; Yang F; Zhou C; Chen Y; Zhang H; Su Z
    J Am Chem Soc; 2014 Dec; 136(52):18023-33. PubMed ID: 25453499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterizing the Free-Energy Landscape of MDM2 Protein-Ligand Interactions by Steered Molecular Dynamics Simulations.
    Hu G; Xu S; Wang J
    Chem Biol Drug Des; 2015 Dec; 86(6):1351-9. PubMed ID: 26032728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.